國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Nanotheranostics for cancer applications

Morris, Stephanie A.

Nanotheranostics for cancer applications

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Nanotheranostics for cancer applicationsedited by Prakash Rai, Stephanie A. Morris.
其他作者:	Rai, Prakash.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	xiv, 480 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Nanomedicine.
電子資源:	https://doi.org/10.1007/978-3-030-01775-0
ISBN:	9783030017750$q(electronic bk.)

Nanotheranostics for cancer applications
Nanotheranostics for cancer applications[electronic resource] /edited by Prakash Rai, Stephanie A. Morris. - Cham :Springer International Publishing :2019. - xiv, 480 p. :ill., digital ;24 cm. - Bioanalysis, advanced materials, methods, and devices,v.52364-1118 ;. - Bioanalysis, advanced materials, methods, and devices ;1..

About the Editors -- List of Contributors -- Part I Introduction to Cancer and Nanotechnology -- 1 Introduction -- 2 Biological Events and Barriers to Effective Delivery of Cancer Therapeutics -- 3 Cancer Diagnostics and Therapeutics -- 4 Nanomedicine in Cancer -- 5 Theranostics: A Historical Perspective of Cancer Nanotechnology Paving the Way for Simultaneous Use Applications -- Part II Cancer Nanodiagnostics and Nanotherapeutics -- 6 In Vitro Cancer Diagnostics -- 7 Translational Nanodiagnostics for In Vivo Cancer Detection -- 8 Delivery of Cancer Nanotherapeutics -- 9 Oral Nanotherapeutics for Cancer with Innovations in Lipid and Polymeric Nanoformulations -- 10 Topical and Transdermal Nanomedicines for Cancer Therapy -- 11 Cancer Nanotherapeutics Administered by Non-Conventional Routes -- Part III Regulatory Considerations for Nanomaterial Drug Products -- 12 Regulatory Considerations for Cancer Drug Products Containing Nanomaterials -- 13 Perspectives for Characterizing Drug Component of Theranostic Products Containing Nanomaterials -- Part IV Cancer Nanotheranostics -- 14 Engineering Multifunctional Nanomedicine Platforms for Drug Delivery and Imaging -- 15 Image-Guided Drug Delivery -- 16 Nanotheranostics-Based Imaging for Cancer Treatment Monitoring -- 17 Remotely-Triggered Nanotheranostics -- 18 Concluding Remarks and the Future of Nanotheranostics -- Index.

This book is the first to focus specifically on cancer nanotheranostics. Each of the chapters that make up this comprehensive volume is authored by a researcher, clinician, or regulatory agency member known for their expertise in this field. Theranostics, the technology to simultaneously diagnose and treat a disease, is a nascent field that is growing rapidly in this era of personalized medicine. As the need for cost-effective disease diagnosis grows, drug delivery systems that can act as multifunctional carriers for imaging contrast and therapy agents could provide unique breakthroughs in oncology. Nanotechnology has enabled the development of smart theranostic platforms that can concurrently diagnose disease, start primary treatment, monitor response and initiate secondary treatments if required. In oncology, chemotherapeutics have been routinely used. Some drugs have proven effective but all carry risks of adverse side effects. There is growing interest in using remotely triggered drug delivery systems to limit cytotoxicity in the diseased area. This book reviews the use of theranostic nanoparticles for cancer applications over the past decade. First, it briefly discusses the challenges and limitations of conventional cancer treatments, and presents an overview of the use of nanotechnology in treating cancer. These introductory chapters are followed by those exploring cancer diagnosis and a myriad of delivery methods for nanotherapeutics. The book also addresses multifunctional platforms, treatment monitoring, and regulatory considerations. As a whole, the book aims to briefly summarize the development and clinical potential of various nanotheranostics for cancer applications, and to delineate the challenges that must be overcome for successful clinical development and implementation of such cancer theranostics. Provides a comprehensive review of cancer nanotheranostics Represents the first book-length treatment of the topic Presents a full picture of the field, from basic research through clinical implementation Features evidence-based chapters with excellent illustrations and images to guide and assist the reader.

ISBN: 9783030017750$q(electronic bk.)

Standard No.: 10.1007/978-3-030-01775-0doiSubjects--Topical Terms:

273406
Nanomedicine.

LC Class. No.: R857.N34 / N366 2019

Dewey Class. No.: 610.28

Nanotheranostics for cancer applications
LDR:04602nmm a2200337 a 4500 001 552408
003 DE-He213
005 20190613100439.0
006 m d
007 cr nn 008maaau
008 191106s2019 gw s 0 eng d
020 $a 9783030017750$q(electronic bk.)
020 $a 9783030017736$q(paper)
024 7 $a 10.1007/978-3-030-01775-0 $2 doi
035 $a 978-3-030-01775-0
040 $a GP $c GP
041 0 $a eng
050 4 $a R857.N34 $b N366 2019
072 7 $a MQW $2 bicssc
072 7 $a TEC009000 $2 bisacsh
072 7 $a MQW $2 thema
082 0 4 $a 610.28 $2 23
090 $a R857.N34 $b N186 2019
245 0 0 $a Nanotheranostics for cancer applications $h [electronic resource] / $c edited by Prakash Rai, Stephanie A. Morris.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xiv, 480 p. : $b ill., digital ; $c 24 cm.
490 1 $a Bioanalysis, advanced materials, methods, and devices, $x 2364-1118 ; $v v.5
505 0 $a About the Editors -- List of Contributors -- Part I Introduction to Cancer and Nanotechnology -- 1 Introduction -- 2 Biological Events and Barriers to Effective Delivery of Cancer Therapeutics -- 3 Cancer Diagnostics and Therapeutics -- 4 Nanomedicine in Cancer -- 5 Theranostics: A Historical Perspective of Cancer Nanotechnology Paving the Way for Simultaneous Use Applications -- Part II Cancer Nanodiagnostics and Nanotherapeutics -- 6 In Vitro Cancer Diagnostics -- 7 Translational Nanodiagnostics for In Vivo Cancer Detection -- 8 Delivery of Cancer Nanotherapeutics -- 9 Oral Nanotherapeutics for Cancer with Innovations in Lipid and Polymeric Nanoformulations -- 10 Topical and Transdermal Nanomedicines for Cancer Therapy -- 11 Cancer Nanotherapeutics Administered by Non-Conventional Routes -- Part III Regulatory Considerations for Nanomaterial Drug Products -- 12 Regulatory Considerations for Cancer Drug Products Containing Nanomaterials -- 13 Perspectives for Characterizing Drug Component of Theranostic Products Containing Nanomaterials -- Part IV Cancer Nanotheranostics -- 14 Engineering Multifunctional Nanomedicine Platforms for Drug Delivery and Imaging -- 15 Image-Guided Drug Delivery -- 16 Nanotheranostics-Based Imaging for Cancer Treatment Monitoring -- 17 Remotely-Triggered Nanotheranostics -- 18 Concluding Remarks and the Future of Nanotheranostics -- Index.
520 $a This book is the first to focus specifically on cancer nanotheranostics. Each of the chapters that make up this comprehensive volume is authored by a researcher, clinician, or regulatory agency member known for their expertise in this field. Theranostics, the technology to simultaneously diagnose and treat a disease, is a nascent field that is growing rapidly in this era of personalized medicine. As the need for cost-effective disease diagnosis grows, drug delivery systems that can act as multifunctional carriers for imaging contrast and therapy agents could provide unique breakthroughs in oncology. Nanotechnology has enabled the development of smart theranostic platforms that can concurrently diagnose disease, start primary treatment, monitor response and initiate secondary treatments if required. In oncology, chemotherapeutics have been routinely used. Some drugs have proven effective but all carry risks of adverse side effects. There is growing interest in using remotely triggered drug delivery systems to limit cytotoxicity in the diseased area. This book reviews the use of theranostic nanoparticles for cancer applications over the past decade. First, it briefly discusses the challenges and limitations of conventional cancer treatments, and presents an overview of the use of nanotechnology in treating cancer. These introductory chapters are followed by those exploring cancer diagnosis and a myriad of delivery methods for nanotherapeutics. The book also addresses multifunctional platforms, treatment monitoring, and regulatory considerations. As a whole, the book aims to briefly summarize the development and clinical potential of various nanotheranostics for cancer applications, and to delineate the challenges that must be overcome for successful clinical development and implementation of such cancer theranostics. Provides a comprehensive review of cancer nanotheranostics Represents the first book-length treatment of the topic Presents a full picture of the field, from basic research through clinical implementation Features evidence-based chapters with excellent illustrations and images to guide and assist the reader.
650 0 $a Nanomedicine. $3 273406
650 0 $a Cancer $x Diagnosis. $3 257242
650 0 $a Cancer $x Treatment. $3 252269
650 1 4 $a Biomedical Engineering and Bioengineering. $3 826326
650 2 4 $a Oncology. $3 195181
650 2 4 $a Nanochemistry. $3 264782
650 2 4 $a Biomaterials. $3 274415
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Biological and Medical Physics, Biophysics. $3 759746
700 1 $a Rai, Prakash. $3 833131
700 1 $a Morris, Stephanie A. $3 833132
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Bioanalysis, advanced materials, methods, and devices ; $v 1. $3 559348
856 4 0 $u https://doi.org/10.1007/978-3-030-01775-0
950 $a Engineering (Springer-11647)